期刊文献+

精准公共卫生研究进展及挑战 被引量:2

Advances and challenges in researches on precision public health
原文传递
导出
摘要 近年来,精准公共卫生在国际医学界迅速兴起。精准公共卫生是以人群为中心,通过基因组学、生物信息技术与大数据、人工智能等工具的交叉应用,定义人群的疾病发生风险,确定可行的干预措施,以精准预测和预防疾病的发生发展,促进人群健康。精准公共卫生在传染病、慢性病、罕见病以及突发公共卫生事件中应用广泛。但是关于如何打破数据壁垒,保护数据隐私以及缺乏标准化的诊断规范仍是当前面临的挑战。本文针对精准公共卫生的定义、影响因素、应用和挑战等方面进行综述。 In recent years,precision public health has rapidly emerged in international medical community.Precision public health is centered on the population,through the cross-application of tools including genomics,bioinformatics,big data and artificial intelligence,to define the risk of disease occurrence in population,determine feasible interventions to accurately predict and prevent the occurrence and development of disease,and promote population health.Precision public health is widely used in dealing with infectious diseases,chronic diseases,rare diseases and public health emergencies.However,there are still some current challenges in breaking the"data barriers",protecting data privacy,and the lack of standardized diagnostic specifications.This article summarizes the definition,influencing factors,application and challenges of precision public health.
作者 杨瑛莹 傅传喜 YANG Ying-ying;FU Chuan-xi(Department of Epidemiology,School of Public Health,Zhejiang Chinese Medical University,Hangzhou,Zhejiang Province 310053,China)
出处 《中国公共卫生》 CAS CSCD 北大核心 2021年第2期371-374,共4页 Chinese Journal of Public Health
关键词 精准公共卫生 影响因素 研究进展 挑战 precision public health influencing factor research advance challenge
  • 相关文献

参考文献2

二级参考文献23

  • 1张思浩,宋修岐.2010~2014年青岛市20~30岁年轻乳腺癌患者流行病学特征[J].临床普外科电子杂志,2014,0(4):19-22. 被引量:1
  • 2National Institutes of Health. About the Precision Medicine Initiative Cohort Program.[EB/OL].[2015-9-17]. http://www.nih.gov/precision-medicine-initiative-cohort-program.
  • 3XieHG, FruehFW. Pharmacogenomics steps toward personalized medicine[J]. Personalized Medicine, 2005,2(4),325-337. DOI: 10.2217/17410541.2.4.325.
  • 4BuguliskisJS. Pharmacogenomics Serves as the Critical Driver for Precision Medicine. Clinical OMICs[J], 2015,2(6),12-16. DOI: 10.1089/clinomi.02.06.06.
  • 5WetterstrandKA. DNA Sequencing Costs: Data from the NHGRI Genome Sequencing Program.[EB/OL].[2016-5-24]. http://www.genome.gov/sequencingcosts.
  • 6JoynerMJ. 'Moonshot' Medicine Will Let Us Down. New York Time[N/OL].[2015-1-29]. http://www.nytimes.com/2015/01/29/opinion/moonshot-medicine-will-let-us-down.html.
  • 7MennelRG. Precision medicine: hype or hope?[J] Proc (Bayl Univ Med Cent). 2015Jul,28(3):397-400.
  • 8BayerR, GaleaS. Public Health in the Precision-Medicine Era[J]. N Engl J Med, 2015,373(6):499-501. DOI: 10.1056/NEJMp1506241.
  • 9ZimmernR, KhouryMJ. Precision Medicine vs. Public Health: a False Dichotomy? CDC Genomics and Health Impact Blog[EB/OL].[2015-9-8]. http://blogs.cdc.gov/genomics/2015/09/28/precision-medicine-2/.
  • 10ForouzanfarMH, AlexanderL, AndersonHR, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2015,386(10010):2287-2323. DOI: 10.1016/S0140-6736(15)00128-2.

共引文献10

同被引文献16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部